Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study.
European journal of cancer (Oxford, England : 1990)·2017
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab).
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Cutaneous immunopathology of long-standing complex regional pain syndrome.
European journal of pain (London, England)·2015
Implications of subcutaneous or intravenous delivery of trastuzumab; further insight from patient interviews in the PrefHer study.
Breast (Edinburgh, Scotland)·2015
'The little things count': delivering dignified care.
Nursing times·2018
The nurse's role in caring for people with dementia.
Nursing times·2018
Implementing change in older people's acute care.
Nursing times·2018
A total health economy approach to revalidation.
Nursing times·2018
Preventing and diagnosing dementia.
Nursing times·2016
The 10 commitments: what they mean to nursing.
Nursing times·2016